Brookstone Capital Management Novo Nordisk A S Transaction History

Brookstone Capital Management

$6.01 Billion
Q3 2024

A detailed history of Brookstone Capital Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Brookstone Capital Management holds 16,408 shares of NVO stock, worth $1.43 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

16,408

Previous 16,594 1.12%

Holding current value

$1.43 Million

Previous $2.37 Million 17.53%

% of portfolio

0.03%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$119.07 - $145.42 $22,147 - $27,048	-186 Reduced 1.12%	16,408 $1.95 Million
Q2 2024 Jul 18, 2024	BUY	$122.71 - $146.91 $67,858 - $81,241	553 Added 3.45%	16,594 $2.37 Million
Q1 2024 Apr 15, 2024	SELL	$102.11 - $135.92 $1.07 Million - $1.42 Million	-10,452 Reduced 39.45%	16,041 $2.06 Million
Q4 2023 Jan 11, 2024	BUY	$87.78 - $105.45 $1.07 Million - $1.28 Million	12,154 Added 84.76%	26,493 $2.74 Million
Q3 2023 Oct 20, 2023	BUY	$90.94 - $199.54 $622,575 - $1.37 Million	6,846 Added 91.37%	14,339 $1.3 Million
Q2 2023 Jul 11, 2023	SELL	$155.98 - $172.65 $39,618 - $43,853	-254 Reduced 3.28%	7,493 $1.21 Million
Q1 2023 Apr 18, 2023	SELL	$132.34 - $159.14 $73,713 - $88,640	-557 Reduced 6.71%	7,747 $1.23 Million
Q4 2022 Jan 09, 2023	BUY	$102.55 - $135.33 $49,121 - $64,823	479 Added 6.12%	8,304 $0
Q3 2022 Oct 13, 2022	SELL	$95.28 - $116.93 $761,096 - $934,036	-7,988 Reduced 50.52%	7,825 $814,000
Q2 2022 Jul 11, 2022	BUY	$103.24 - $121.81 $882,908 - $1.04 Million	8,552 Added 117.78%	15,813 $1.72 Million
Q1 2022 Apr 12, 2022	SELL	$93.1 - $112.54 $25,695 - $31,061	-276 Reduced 3.66%	7,261 $878,000
Q4 2021 Jan 11, 2022	SELL	$95.88 - $117.08 $27,709 - $33,836	-289 Reduced 3.69%	7,537 $765,000
Q3 2021 Nov 03, 2021	SELL	$84.42 - $106.62 $13,591 - $17,165	-161 Reduced 2.02%	7,826 $787,000
Q2 2021 Jul 14, 2021	SELL	$67.66 - $84.76 $7,713 - $9,662	-114 Reduced 1.41%	7,987 $692,000
Q1 2021 Apr 16, 2021	BUY	$67.06 - $75.82 $13,009 - $14,709	194 Added 2.45%	8,101 $546,000
Q4 2020 Jan 13, 2021	BUY	$63.89 - $73.8 $9,839 - $11,365	154 Added 1.99%	7,907 $552,000
Q3 2020 Oct 13, 2020	SELL	$63.69 - $70.22 $16,941 - $18,678	-266 Reduced 3.32%	7,753 $538,000
Q2 2020 Jul 21, 2020	SELL	$58.54 - $67.94 $185,103 - $214,826	-3,162 Reduced 28.28%	8,019 $525,000
Q1 2020 Apr 14, 2020	SELL	$49.46 - $64.78 $14,689 - $19,239	-297 Reduced 2.59%	11,181 $673,000
Q4 2019 Jan 29, 2020	SELL	$49.86 - $58.26 $1,844 - $2,155	-37 Reduced 0.32%	11,478 $664,000
Q3 2019 Oct 18, 2019	BUY	$47.54 - $53.43 $32,041 - $36,011	674 Added 6.22%	11,515 $595,000
Q2 2019 Jul 25, 2019	BUY	$46.79 - $52.47 $110,143 - $123,514	2,354 Added 27.74%	10,841 $553,000
Q1 2019 Apr 18, 2019	BUY	$46.36 - $52.63 $58,691 - $66,629	1,266 Added 17.53%	8,487 $444,000
Q4 2018 Feb 06, 2019	BUY	$41.54 - $47.25 $22,223 - $25,278	535 Added 8.0%	7,221 $333,000
Q3 2018 Nov 05, 2018	BUY	$46.76 - $51.24 $312,637 - $342,590	6,686 New	6,686 $315,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookstone Capital Management with notifications on news.

Account

Brookstone Capital Management Novo Nordisk A S Transaction History